Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A novel iron chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1G93A ALS mice
"You have to know conversions, and you have to know how much to draw up, says Janice Jin Hwang, an endocrinologist at University of North Carolina at Chapel Hill
Design: Randomized, double-blind, placebo-controlled Phase 2 trial
Plozasiran Now Available in China: A Once-Every-3-Month siRNA Therapy for Familial Chylomicronemia Syndrome (FCS) Plozasiran now available in China marks a milestone for FCS patients, offering a new APOC3-targeted siRNA therapy to help lower triglyceride (TG) levels in adults Ciprocopan Approved in China as the Worlds First Once-Daily Oral CFB Inhibitor for PNH Ciprocopan approved in China as the worlds first once-daily oral Complement Factor B (CFB) inhibitor, bringing a new oral treatment option for patients with paroxysmal Oveporexton Approved First in China: The First OX2R Agonist Targeting the Underlying Mechanism of Type 1 Narcolepsy Oveporexton approved first in China, becoming the worlds first approved selective orexin receptor 2 (OX2R) agonist and the first therapy designed to target the underlying Gene Therapy for Beta Thalassemia: Can CRISPR and Gene Addition Achieve Transfusion Independence
[1] [4] If you need to change your weekly dosing day after starting treatment, you may do so as long as your last dose was administered at least 72 hours (3 days) prior to the new dosing day
